Other age-related co-variables such as primary sclerosing cholangitis and the potential presence of breast cancer susceptibility genes 1/2 (BRCA1/2) mutations may be enriched in those <40 years and may confound OS outcomes. This evidence concerns the gene BRCA1 and sclerosing cholangitis.